COVID-19 and Endocrine Disease

ESE: Raising awareness of the links between endocrinology and COVID-19:

During this challenging period of the COVID-19 pandemic, ESE recognises the hard work and dedication of all endocrinologists across the world, and in particular our members, as they strive to continue to support their patients and develop new care pathways. ESE is working actively at the EU level to raise awareness about the links between endocrinology, COVID-19 and metabolic diseases.

You can read our latest position paper HERE and a condensed version of the same paper HERE.

In addition, ESE has, and continues to, develop and provide resources for use by the whole endocrine community during this time. We hope these are of interest and benefit. Discover our clinical information and resources HERE.

Note: After additional feedback from experts, the reference to people suffering from auto-immune thyroid disease as a population that would face an increased risk of and/or from infection has been deleted as there is no clear evidence to support this. A follow-up statement about a specific concern for the millions of patients suffering from thyroid related disorders has been erroneously attributed to the article Endocrinology in the time of COVID-19: management of hyperthyroidism and hypothyroidism; Boelaert K et al, Eur J Endocrinol. 2020 Jul:G33-G39, and has been deleted.


ESE & COVID-19 and EU4Health. 

ESE’s experts have been very active since the pandemic started, identifying links between COVID-19 and endocrinology. Our latest position paper on the topic can be found here. Recently (15 February 2021) Member of the European Parliament (MEP) Sirpa Pietikäinen (Finland, European People’s Party) echoed our call for a stronger policy response in the Parliament Magazine. Read her article here.